The Churg–Strauss Syndrome after Pranlukast Treatment in a Patient Not Receiving Corticosteroids

  1. Takashi Katsura, MD;
  2. Fumihide Yoshida, MD; and
  3. Yasutaka Takinishi, MD
  1. From Showa University Toyosu Hospital; Tokyo, 135-8577 Japan.

    The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

    •Include no more than 300 words of text, three authors, and five references

    •Type with double-spacing

    •Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

    Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

    Annals welcomes electronically submitted letters.

    TO THE EDITOR:

    The Churg–Strauss syndrome is a disorder characterized by eosinophilic inflammation and necrotizing vasculitis associated with asthma and blood eosinophilia (1). Since Wechsler and colleagues (2) reported the case series in …

    « Previous | Next Article »Table of Contents